Skip to main content
Log in

The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL)

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Interferon gamma (IFN-γ) and interleukin 6 (IL-6) are including the most important cytokines which have been associated with the biological behavioral and immune responses in malignancies. Based on the critical roles which these two cytokines play against tumor cells, the present study was aimed to investigate the genes expression level of IL6 and IFN-γ in patients with Acute Lymphoblastic Leukemia and compare with normal controls. Fifty-two patients with ALL and 13 healthy volunteer were under studied. The peripheral blood mononuclear cells of all patients and normal controls were separated by ficoll. The expression of interferon gamma and interleukin 6 genes were determined by RQ-PCR. Finally all data were analyzes using T student, one way ANOVA and Mann-Whitney tests were use to analyze all samples data. Our finding showed that the level of IFN-γ gene expression was significant decreased in patients with All as compared with healthy controls (83 change fold, p < 0.0001). The level of IL-6 Gene expression was not changeable in B-ALL patients as compared with healthy control (p = 0.4), but in T-ALL patients, was significantly reduced (p < 0.01). The results of present study indicated that IFN-γ gene expression reduced in ALL patients. It provides a valuable insight that immune system may disrupted in patients with ALL, which cause tumor cells escape from immune surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Harrison CJ (2013) Targeting signaling pathways in acute lymphoblastic leukemia: new insights. American Society of Hematology, Education Program 2013(1):118–125

    Article  Google Scholar 

  2. Cardoso B, Gírio A, Henriques C, Martins L, Santos C, Silva A et al (2008) Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications. Braz J Med Biol Res 41(5):344–350

    Article  CAS  Google Scholar 

  3. Brady MT, Lee J, Ferrone S et al (2011) Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia- derived dendritic cells. American Society of Hematology, Education Program 35(2):275–277

    CAS  Google Scholar 

  4. Kholoussi SM, Bayoumi FS, El-Nady H (2008) Estimation of serum interferon-gamma level in childhood acut lymphoblastic leukemia patients. J Med Sci 8(1):68–72

    Article  CAS  Google Scholar 

  5. Marth C, Fiegl H, Zeimet AG et al (2004) Interferon-g expression is an independent prognostic factor in ovarian cancer. Am J Obstet Gynecol 191:1598–1605

    Article  CAS  Google Scholar 

  6. Tian G, Mi J, Wei X, Zhao D, Qiao L, Yang C, Li X et al (2015) Circulating interleukin-6 and cancer: a meta-analysis using Mendelian randomization. Sci Rep

  7. Heikkila K, Ebrahim S, Lawlor DA (2008) Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 44:937–945

    Article  CAS  Google Scholar 

  8. Sugiyama H, Inoue K, Ogawa H, Yamagami T, Soma T, Miyake S, Hirata M, Kishimoto T (1995) The expression of IL-6 and its related genes in acute leukemia. Leuk Lymphoma 21:1

    CAS  Google Scholar 

  9. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. J Biochem 374(1):1–20

    Article  CAS  Google Scholar 

  10. Bauvois B, Nguyen J, Tang R, Billard C, Kolb J-P (2009) Types I and II interferon supregulate the co-stimulatory CD80 molecule in monocytes via interferon regulatory factor. Biochem Pharmacol 8(5):514–522

    Article  Google Scholar 

  11. Sato A, Ohtsuki M, Hata M et al (2006) Antitumor activity of IFN- in murine tumor models. J Immunol 176:7686–7694

    Article  CAS  Google Scholar 

  12. Fujii H, Trudeau JD, Teachey DT, Fish JD, Stephan A et al (2007) In vivo control of acute lymphoblastic leukemia by immuno stimulatory Cp Goligonucleotides. Blood 1090:5.2008–5.2013

    Google Scholar 

  13. Yin HQ, Qiao ZH, Zhu L, Zhang L, Su LP, Lu YJ (2006) Levels of intracellular IL-6 and IFN-gamma in children with acute lymphoblastic leukemia. American Society of Hematology, Education Program 8(6):461–463

    CAS  Google Scholar 

  14. HeePark H, Kim M, Lee B-H et al (2006) Intracellular IL-4, IL-10, and IFN-γ levels of leukemic cells and bone marrow T cells in acute leukemia. Ann Clin Lab Sci 36:15–17

    Google Scholar 

  15. Zhang X-I, Komada Y, Joe C (2000) Intracellular cytokine pro®le of T cells with acute lymphoblastic leukemia. Cancer Immunol Immunother 49(3):165–172

    Article  CAS  Google Scholar 

  16. Strander H (1986) Interferon treatment of human neoplasia. Adv Cancer Res 46:1

    Article  CAS  Google Scholar 

  17. De Maeyer E, De Maeyer-Guignard J (1988) Interferons and other regulatory cytokines. Wiley, New York, pp 134–334

    Google Scholar 

  18. Grandér D, Heyman M, Brondum-Nielsen K, Liu Y, Lundgren E, Soderhall S, Einhorn S (1992) Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the <w-/P-interferon genes. Blood 79(8):2076–2083

    Article  Google Scholar 

  19. Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K (2005) Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia. Cancer 103(4):1054–1063

    Article  CAS  Google Scholar 

  20. Morales T, Rojas NV et al (2012) Proinflammatory cytokines during the initial phase of oralmucositis in patients with acute lymphoblastic leukaemia. Int J Paediatr Dent 22:191–196

    Article  Google Scholar 

  21. Luo Y, Huang Z, Qian H et al (1993) Tumor necrosis factor and interleukin 6 in acute leukemia. Zhonghua nei ke za zhi 32(2):85–87

  22. Pituch-Noworolska A, Wieckiewicz J, Gawlicka M et al (1998) The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF. Haematologia 29(2):101–114

    CAS  PubMed  Google Scholar 

  23. Sanchez-Correa B, Berqua JM, Campos C et al (2013) Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 61(3):885–891

Download references

Acknowledgments

Authors would like to thank the deputy research of Shahid Beheshti University of medical Science (School of Allied medical Sciences) for supporting and providing research facilities.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohsen Hamidpour.

Ethics declarations

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allahbakhshian Farsani, M., Kamel, M., Mehrpouri, M. et al. The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL). Pathol. Oncol. Res. 26, 461–466 (2020). https://doi.org/10.1007/s12253-018-0536-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0536-z

Keywords

Navigation